Louis Levy
la Mesa, CANPI 1225037336
Payments from drug & device makers
What this record shows
7 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 58.3% of the total.
Across 11 payments — averaging $50.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$321
- Amgen$88
- Mallinckrodt Enterprises LLC$53
- Mallinckrodt Hospital Products Inc.$34
- UCB, Inc.$21
- Sanofi-aventis U.S. LLC$20
- plus $14 from 1 others
Across 45 payments — averaging $10,542 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pacira Therapeutics, Inc.$152K
- Microport Orthopedics Inc$149K
- Novartis$120K
- Regeneron$43K
- Acadia Pharmaceuticals Inc$11K
- Anika Therapeutics, Inc.$350
What the payments were for
- Speaking & faculty fees$32158%
- Food & beverage$23042%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 1 | $321 |
| Amgen | 4 | $88 |
| Mallinckrodt Enterprises LLC | 2 | $53 |
| Mallinckrodt Hospital Products Inc. | 1 | $34 |
| UCB, Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPAREL$321
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.